Reintervention Before Bidirectional Cavopulmonary Shunt and Intermediate Outcomes in Children with Single Ventricle

Bhavikkumar D Langanecha1, Sajith Kesavan2, Steven M Schwartz3,4

  • 1Labatt Family Heart Centre, Division of Pediatric Cardiology, Department of Pediatrics, University of Toronto, Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada. bhavikkumar.langanecha@sickkids.ca.

Pediatric Cardiology
|July 31, 2023
PubMed

Insights

Unplanned reinterventions after pulmonary artery banding (PAB) in single ventricle patients are common. Genetic syndromes are a risk factor for poor outcomes, necessitating further research into alternative palliative strategies for these patients.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Surgical Palliation

Background:

  • Pulmonary artery banding (PAB) is a palliative procedure for single ventricle (SV) patients.
  • Unplanned reinterventions are frequent before stage 2 palliation (S2P) in SV patients post-PAB.
  • Risk factors for these reinterventions remain largely unknown.

Purpose of the Study:

  • To identify risk factors associated with reinterventions after PAB in SV patients.
  • To evaluate the impact of reinterventions on the success of subsequent stage 2 palliation.
  • To explore outcomes in SV patients with genetic syndromes undergoing PAB.

Main Methods:

  • Retrospective single-center study of 77 SV patients undergoing PAB (2000-2020).
  • Cause-specific hazard regression and competing risk models analyzed reintervention and S2P rates.
  • Multivariable models adjusted for clinical and statistical predictors.

Main Results:

  • 13% of patients required reintervention within 18 months of PAB.
  • Reinterventions included PAB adjustment (60%) and shunt conversion (40%).
  • Genetic syndromes (p=0.025) were associated with poor outcomes, with only 25% reaching S2P.

Conclusions:

  • PAB offers reasonable outcomes in SV patients but has a high reintervention rate.
  • Genetic syndromes are a significant risk factor for adverse outcomes post-PAB.
  • Alternative palliative strategies should be investigated for SV patients with genetic syndromes.